TrialInternational journal of cancer2022

Human papillomavirus-based screening at extended intervals missed fewer cervical precancers than cytology in the HPV For Cervical Cancer (HPV FOCAL) trial.

Anna Gottschlich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.